Skip to main content
logo
Forte Biosciences, Inc. (FBRX)
Aug 27, 2026 - FBRX was delisted (reason: acquired by ARGX)
76.99
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2026

Forte Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,939486145302132
Market Cap Growth
860.99%234.91%386.30%42.17%-33.49%-93.24%
Enterprise Value
1,741393129-16-23-14
Last Close Price
76.9927.2722.7120.5425.0053.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
10.247.972.770.850.540.76
P/TBV Ratio
10.557.972.770.850.540.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.08-1.26-1.11-1.05-1.06-1.01
Net Debt / EBITDA Ratio
2.101.091.601.142.971.96
Net Debt / FCF Ratio
2.761.511.901.295.022.52
Quick Ratio
9.823.756.4410.1312.9323.92
Current Ratio
10.013.886.7610.4613.0624.19
Return on Equity (ROE)
-62.28%-122.28%-80.82%-84.92%-34.54%-43.19%
Return on Assets (ROA)
-37.79%-61.19%-45.51%-50.15%-20.36%-25.69%
Return on Capital Employed (ROCE)
-51.10%-113.90%-69.70%-92.00%-35.80%-51.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.54%-14.27%-24.44%-105.42%-66.09%-68.75%
FCF Yield
-3.71%-10.49%-21.20%-96.44%-38.98%-52.82%
Buyback Yield / Dilution
-148.66%-404.74%-130.90%-81.61%-24.45%-89.81%
SEC Filings: 10-K · 10-Q